Please use this identifier to cite or link to this item: https://doi.org/10.3389/fimmu.2021.721722
DC FieldValue
dc.titleNon-Stimulatory pMHC Enhance CD8 T Cell Effector Functions by Recruiting Coreceptor-Bound Lck
dc.contributor.authorZhao, Xiang
dc.contributor.authorWu, Liang-Zhe
dc.contributor.authorNg, Esther K. Y.
dc.contributor.authorLeow, Kerisa W. S.
dc.contributor.authorWei, Qianru
dc.contributor.authorGascoigne, Nicholas R. J.
dc.contributor.authorBrzostek, Joanna
dc.date.accessioned2022-10-13T07:31:56Z
dc.date.available2022-10-13T07:31:56Z
dc.date.issued2021-10-11
dc.identifier.citationZhao, Xiang, Wu, Liang-Zhe, Ng, Esther K. Y., Leow, Kerisa W. S., Wei, Qianru, Gascoigne, Nicholas R. J., Brzostek, Joanna (2021-10-11). Non-Stimulatory pMHC Enhance CD8 T Cell Effector Functions by Recruiting Coreceptor-Bound Lck. Frontiers in Immunology 12 : 721722. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2021.721722
dc.identifier.issn1664-3224
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/233112
dc.description.abstractUnder physiological conditions, CD8+ T cells need to recognize low numbers of antigenic pMHC class I complexes in the presence of a surplus of non-stimulatory, self pMHC class I on the surface of the APC. Non-stimulatory pMHC have been shown to enhance CD8+ T cell responses to low amounts of antigenic pMHC, in a phenomenon called co-agonism, but the physiological significance and molecular mechanism of this phenomenon are still poorly understood. Our data show that co-agonist pMHC class I complexes recruit CD8-bound Lck to the immune synapse to modulate CD8+ T cell signaling pathways, resulting in enhanced CD8+ T cell effector functions and proliferation, both in vitro and in vivo. Moreover, co-agonism can boost T cell proliferation through an extrinsic mechanism, with co-agonism primed CD8+ T cells enhancing Akt pathway activation and proliferation in neighboring CD8+ T cells primed with low amounts of antigen. © Copyright © 2021 Zhao, Wu, Ng, Leow, Wei, Gascoigne and Brzostek.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2021
dc.subjectAKT pathway
dc.subjectco-agonism
dc.subjectLck
dc.subjectnon-stimulatory peptide MHC
dc.subjectT cell effector functions
dc.subjectT cell receptor
dc.subjectT cell signaling
dc.typeArticle
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.doi10.3389/fimmu.2021.721722
dc.description.sourcetitleFrontiers in Immunology
dc.description.volume12
dc.description.page721722
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fimmu_2021_721722.pdf2.73 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons